ALEXANDRIA, Va., June 19 -- United States Patent no. 12,332,255, issued on June 17, was assigned to The Regents of the University of Colorado (Denver).

"Methods for monitoring treatment of chronic liver disease" was invented by Gregory Thomas Everson (Englewood, Colo.) and Steve Mark Helmke (Denver).

According to the abstract* released by the U.S. Patent & Trademark Office: "A Disease Severity Index (DSI) is provided for assessment of chronic liver disease in a patient using non-invasive liver function test results. A DSI was derived from non-invasive liver function test results based on hepatic blood flow. The DSI is used in methods for prediction of clinical outcomes, prediction of response to antiviral treatment, and assessment of prog...